Bellevue Group AG

Q2 2019 13F Holdings Report, Stock Holdings

Signature - Title
Michael Hutter - CFO
Location
Kuesnacht, Switzerland
Holdings as of
June 30, 2019
Value $
$5.86B
Num holdings
201
Date filed
8/14/2019, 02:28 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, INCY, NBIX, VRTX, and SAGE.
Previous filing
Q1 2019 - May 15, 2019
Next filing
Q3 2019 - Nov 14, 2019
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q2 compared to 2019 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Michael Hutter CFO Kuesnacht, Switzerland 8/13/2019

Other Included Managers (6):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Biotech Focus N. V. Willemstad, Netherlands Antilles 028-11193
3 Biotech Invest N V Willemstad, Netherlands Antilles 028-11191
4 Biotech Target N V Willemstad, Netherlands Antilles 028-11189
5 Biotech Growth N V Willemstad, Netherlands Antilles 028-11194
6 Bellevue Asset Management AG Zurich 028-16892